2-amino-5-phosphonovalerate has been researched along with tcn 201 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hermann, GE; Rogers, RC; Vance, KM | 1 |
Dominic, D; Punnakkal, P | 1 |
2 other study(ies) available for 2-amino-5-phosphonovalerate and tcn 201
Article | Year |
---|---|
NMDA receptors control vagal afferent excitability in the nucleus of the solitary tract.
Topics: 2-Amino-5-phosphonovalerate; Adenosine Triphosphate; Afferent Pathways; Animals; Aspartic Acid; Benzimidazoles; Calcium; Excitatory Amino Acid Antagonists; In Vitro Techniques; Piperidines; Pregnenolone; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate; Solitary Nucleus; Sulfonamides; Vagus Nerve | 2015 |
NMDA Receptor GluN2 Subtypes Control Epileptiform Events in the Hippocampus.
Topics: 2-Amino-5-phosphonovalerate; Age Factors; Animals; Animals, Newborn; CA1 Region, Hippocampal; Dentate Gyrus; Epilepsy; Excitatory Amino Acid Antagonists; Female; Male; Organ Specificity; Phenols; Piperidines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Sulfonamides | 2018 |